<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744356/" ref="ordinalpos=1157&amp;ncbi_uid=2024433&amp;link_uid=PMC2744356" image-link="/pmc/articles/PMC2744356/figure/F1/" class="imagepopup">Fig 1. TLR <span class="highlight" style="background-color:">signaling</span>.  From: Toll-like receptors in skin infectious and inflammatory diseases. </a></div><br /><div class="p4l_captionBody">Upon the stimulation by cognate ligands, all TLRs, except for TLR3, recruit MyD88, IRAKs and TRAF6 to activate TLR signaling. Subsequently, TLR signaling diverges at TRAF6 to two different pathways to produce inflammatory cytokines. However, TLR3 utilizes TRIF for the activation of the TRIF-dependent pathway to produce type I interferons and inflammatory cytokines.</div></div>